Bisoprolol transdermal patch improves orthostatic hypotension in patients with chronic heart failure and hypertension
β blockers (BBs) play an important role in heart failure (HF) treatment. However, orthostatic hypotension (OH) is sometimes caused by BBs. The bisoprolol transdermal patch works more slowly and is long acting compared with the bisoprolol fumarate tablet. The risk of OH may be reduced by using the bi...
Main Authors: | Shunsuke Kiuchi, Shinji Hisatake, Takayuki Kabuki, Takashi Oka, Shintaro Dobashi, Takahiro Fujii, Takahide Sano, Takanori Ikeda |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2020-08-01
|
Series: | Clinical and Experimental Hypertension |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10641963.2020.1723616 |
Similar Items
-
THE USE OF BETA-BLOCKER BISOPROLOL FOR THE PREVENTION OF HIGH BLOOD PRESSURE IN WOMEN WITH IDIOPATHIC ARTERIAL HYPOTENSION
by: M. P. SAVENKOV, et al.
Published: (2016-12-01) -
A Comparative Study to Investigate the Effects of Bisoprolol in Patients with Chronic Heart Failure and Hypertension When Switched from Tablets to Transdermal Patches
by: Akira Sezai, et al.
Published: (2023-05-01) -
Impact of bisoprolol transdermal patch on early recurrence during the blanking period after atrial fibrillation ablation
by: Yuya Suzuki, et al.
Published: (2021-06-01) -
State of the art for diagnosis and treatment of orthostatic hypotension
by: A V Aksenova, et al.
Published: (2018-06-01) -
EXPERIENCE IN THE USE OF BISOPROLOL IN THE TREATMENT OF OUTPATIENT HYPERTENSIVE PATIENTS AFTER STROKE
by: I. I. Esenova, et al.
Published: (2015-09-01)